Physician profile
Nathaniel George
NPI 1154784486
$19,335.35
in general payments reported to CMS, 2019-2025
36 companies · $4,386 in 2025
The $4,386 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.72 · 2020: $496 · 2021: $2,290 · 2022: $3,324 · 2023: $5,354 · 2024: $3,420 · 2025: $4,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,427 · Travel and Lodging: $3,701 · Gift: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,427.41 |
| Travel and Lodging | $3,700.64 |
| Gift | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,588.65 | 2021-2025 | Prostep, Ortholoc 3di, Graftjacket |
| Kerecis Limited | $2,130.24 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $2,090.20 | 2020-2025 | Puraply, Puraply Franchise, Puraply Wound Matrix |
| Treace Medical Concepts, INC. | $1,804.37 | 2021-2025 | |
| Medline Industries LP | $1,556.04 | 2023 | |
| Smith+Nephew, INC. | $1,174.01 | 2019-2025 | Collagenase Santyl, Regranex |
| Biotissue Holdings INC. | $963.48 | 2022 | |
| Lightbody Medical Technologies INC | $839.80 | 2024-2025 | |
| Arthrex, INC. | $776.38 | 2022-2025 | |
| Medwest Associates | $688.22 | 2021-2023 | |
| Lifenet Health | $677.54 | 2024 | Theragenesis Wound Matrix |
| Orthofix Medical, INC. | $608.21 | 2020-2025 | Physio-Stim |
| Acera Surgical, INC. | $334.15 | 2021-2024 | Restrata Wound Matrix |
| Bone Support INC. | $331.64 | 2024 | Cerament G, Ceramentbone Void Filler |
| Paratek Pharmaceuticals, INC. | $307.85 | 2025 | Nuzyra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $304.00 | 2023-2024 | Colink 2, Biobrace 23mm |
| Acumed LLC | $271.41 | 2023 | Osteomed, Acumed |
| Medtronic, INC. | $267.84 | 2024 | Synchromedii, Intellis Adaptivestim |
| Mimedx Group, INC. | $264.07 | 2024-2025 | |
| Misonix INC | $236.80 | 2019-2021 | |
| Paragon 28, INC. | $226.63 | 2020-2025 | Lisfranc, Ankle Fracture, Mtp |
| Integra Lifesciences Corporation | $184.89 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $123.63 | 2025 | Exparel |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Horizon Therapeutics Plc | $115.66 | 2023 | Krystexxa |
| Depuy Synthes Sales INC. | $68.34 | 2025 | Motoband |
| Arteriocyte Medical Systems, INC. | $53.98 | 2023 | Magellan |
| Polynovo North America LLC | $39.54 | 2023 | |
| Reprise Biomedical, INC. | $36.69 | 2024 | Miro3d |
| Ets Wound Care LLC | $36.17 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Abbott Laboratories | $23.81 | 2023 | Proclaim |
| Ermi LLC | $21.39 | 2025 | |
| Fusion Orthopedics USA, LLC | $20.03 | 2023-2025 | |
| Innovation Technologies INC | $19.94 | 2023 | Irrisept |
| Hartmann USA, INC. | $18.43 | 2025 | Zetuvit Plus 10x10 P10 |
| Amgen INC. | $14.37 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.